Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

Giuseppe Boriani; Marco Proietti; Cécile Laroche; Laurent Fauchier; Francisco Marı́n; Michael Näbauer; Tatjana Potpara; Gheorghe‐Andrei Dan; Zbigniew Kalarus; Luigi Tavazzi; Aldo P. Maggioni; Professor Gregory Lip; Giuseppe Boriani; G Y H Lip; Luigi Tavazzi; Aldo P. Maggioni; G-A Dan; T Potpara; M Nabauer; Francisco Marı́n; Z Kalarus; A Goda; G Mairesse; T Shalganov; Loizos Antoniades; Miloš Táborský; S Riahi; Ignacio García Bolao; O Piot; Michael Näbauer; Kakhaber Etsadashvili; E Simantirakis; Moti Haim; Amirhossein Azhari; J Najafian; M Santini; Erkin М Мirrakhimov; K a Kulzida; A Erglis; L Poposka; M Burg; Ö Erküner; D Atar; Mário Oliveira; D Shah; G-A Dan; E Serdechnaya; T Potpara; E Diker; D Lane; E Zëra; U Ekmekçiu; V Paparisto; Mihal Tase; H Gjergo; J Dragoti; A Goda; M Ciutea; N. Ahadi; Ziad El Husseini; M Raepers; J. Leroy; P Haushan; Aurélie Jourdan; C Lepiece; L Desteghe; Johan Vijgen; P Koopman; G Van Genechten; H Heidbuchel; Tim Boussy; M De Coninck; Hannelore Van Eeckhoutte; N Bouckaert; A Friart; J Boreux; C Arend; P Evrard; L Stefan; E Hoffer; J Herzet; M Massoz; C Celentano; M Sprynger; Luc Piérard; P Melon; B Van Hauwaert; C Kuppens; D Faes; Dirk van Lier; A. Van Dorpe; A Gerardy; Olivier Deceuninck; Olivier Xhaët

doi:10.1093/europace/euz032

Abstract

1 min read

The 1-year follow-up of EORP-AF General Long-Term Registry reported a low occurrence of thromboembolic and haemorrhagic events, although mortality was high. Both VKA and NOACs were associated with a lower risk of all main adverse outcomes. All treatments were associated with a lower risk for CV death and all-cause death.

Related publications

Article2020

Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry

Marco Vitolo, Marco Proietti, Stephanie L. Harrison, Zbigniew Kalarus, Luigi Tavazzi, Tatjana Potpara, Deirdre A. Lane, Giuseppe Boriani, Professor Gregory Lip

Article2020

Impact of body mass index on outcomes in European patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term registry (AFGen LT)

Giuseppe Boriani, Marco Proietti, C Laroche, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gaita Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Professor Gregory Lip

Article2021

684 Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Marrco Vitolo, Vincenzo Livio Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Deirdre A. Lane, Professor Gregory Lip, Giuseppe Boriani

Article2025

Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III

Yang Liu, Steven Ho Man Lam, Giulio Francesco Romiti, Bi Huang, Yang Chen, Tze-Fan Chao, Brian Olshansky, Kui Hong, Menno V. Huisman, Professor Gregory Lip

Article2019

P3784Impact of progressively impaired renal function on major adverse outcomes in European patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry

Giuseppe Boriani, Marco Proietti, C Laroche, Igor Diemberger, Zbigniew Kalarus, Tatjana Potpara, Laurent Fauchier, Harry J.G.M. Crijns, Aldo P. Maggioni, Professor Gregory Lip